Related references
Note: Only part of the references are listed.Lysosomal SLC46A3 modulates hepatic cytosolic copper homeostasis
Jung-Hwan Kim et al.
NATURE COMMUNICATIONS (2021)
A genome-wide CRISPR/Cas9 screen reveals that the aryl hydrocarbon receptor stimulates sphingolipid levels
Saurav Majumder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
Annelise M. Poss et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Metabolic impact of persistent organic pollutants on gut microbiota
Yuan Tian et al.
GUT MICROBES (2020)
2,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice
Kelly A. Fader et al.
SCIENTIFIC REPORTS (2019)
Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model
Caroline Duval et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2017)
Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity
Kelly A. Fader et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Rance Nault et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis
Hiroshi Tsugawa et al.
NATURE METHODS (2015)
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Changtao Jiang et al.
NATURE COMMUNICATIONS (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The adipokine/ceramide axis: Key aspects of insulin sensitization
Jonathan Y. Xia et al.
BIOCHIMIE (2014)
Effects of in Utero Exposure of C57BL/6J Mice to 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Epidermal Permeability Barrier Development and Function
Clarisse S. Muenyi et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2014)
2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Production of Reactive Oxygen Species Is An Essential Step in the Mechanism of Action to Accelerate Human Keratinocyte Differentiation
Lawrence H. Kennedy et al.
TOXICOLOGICAL SCIENCES (2013)
Ceramide synthases at the centre of sphingolipid metabolism and biology
Thomas D. Mullen et al.
BIOCHEMICAL JOURNAL (2012)
Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner
Rachel Tanos et al.
HEPATOLOGY (2012)
Role of ceramides in nonalcoholic fatty liver disease
Mangesh Pagadala et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
A Novel Role for the Dioxin Receptor in Fatty Acid Metabolism and Hepatic Steatosis
Jung Hoon Lee et al.
GASTROENTEROLOGY (2010)
Automated Dose-Response Analysis of the Relative Hepatic Gene Expression Potency of TCDF in C57BL/6 Mice
Lyle D. Burgoon et al.
TOXICOLOGICAL SCIENCES (2009)
12(R)-Hydroxy-5(Z),8(Z),10(E),14(Z)-eicosatetraenoic Acid [12(R)-HETE], an Arachidonic Acid Derivative, Is an Activator of the Aryl Hydrocarbon Receptor
Christopher. R. Chiaro et al.
MOLECULAR PHARMACOLOGY (2008)
Characterization of ceramide synthase 2 - Tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate
Elad L. Laviad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Kinetic characterization of mammalian ceramide synthases:: Determination of Km values towards sphinganine
Sujoy Lahiri et al.
FEBS LETTERS (2007)
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
William L. Holland et al.
CELL METABOLISM (2007)
Sphingolipids as modulators of cancer cell death:: Potential therapeutic targets
Bruno Segui et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Functional characterization of the promoter for the mouse SPTLC2 gene, which encodes subunit 2 of serine palmitoyltransferase
Stephen C. Linn et al.
FEBS LETTERS (2006)
Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production
John S. Millar et al.
JOURNAL OF LIPID RESEARCH (2006)
Association of ceramides in human plasma with risk factors of atherosclerosis
Ikuyo Ichi et al.
LIPIDS (2006)
When do lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis
Yael Pewzner-Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-mediated hepatotoxicity
DR Boverhof et al.
TOXICOLOGICAL SCIENCES (2005)
AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells
S Roblin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Human and mouse gene structure: Comparative analysis and application to exon prediction
S Batzoglou et al.
GENOME RESEARCH (2000)
Share Paper
